VGTEL, Inc. (OTC: VGTL) announced on March 24, 2026, that it has entered formal strategic discussions with Bell Rose Capital Inc. (OTC: BELR) regarding the potential acquisition of a next-generation health-technology application developed by 4biddenknowledge Inc., a wholly owned subsidiary of Bell Rose. The move underscores VGTEL's expansion into data-driven health technology and emerging consciousness-focused innovation.
The health-tech app, described as a pre-revenue but high-potential digital wellness platform, represents a new class of emerging health technology designed to support users through advanced data-driven insights and an intuitive user experience. While the product has not yet generated sales, early technical evaluations indicate strong scalability and alignment with VGTEL’s expanding technology roadmap.
Billy Carson, President of Bell Rose Capital and founder of 4biddenknowledge Inc., is widely recognized for his multidisciplinary research spanning ancient civilizations, UAP and extraterrestrial phenomena, and the intersection of science and consciousness. Through his work, Carson has consistently explored how advanced knowledge systems relate to human awareness, cognitive development, and technological evolution, with a particular emphasis on consciousness research matching growing scientific interest in brain activity and human potential.
“This health-tech platform reflects years of innovation inside 4biddenknowledge,” Carson said. “Our work has always focused on understanding the deeper connections between knowledge, technology, and human consciousness. VGTL is building an ecosystem where emerging technologies can be developed, refined, and deployed at scale. If this transaction moves forward, I’m prepared to support that mission as an advisor.”
Ken Williams, CEO of VGTEL, emphasized the strategic fit. “This technology fits directly into VGTL’s emerging-tech mandate. We see meaningful potential not only in the platform itself, but also in the broader perspective Billy Carson brings, particularly his work at the intersection of consciousness, advanced research, and future technologies. These discussions reflect our commitment to identifying early-stage technologies with long-term commercial promise.”
Both companies confirmed that negotiations are active and constructive, with due diligence underway and a shared focus on responsible development, scalability, and future commercialization. Updates will be forthcoming as the process advances.
